ArticleCardiovascular diabetology. Endocrinology reports2025
Managing type 2 diabetes during the COVID-19 pandemic in Ghana: a qualitative study.
Article in Cardiovascular diabetology. Endocrinology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Living with type 2 diabetes: stress and daily life challenges among adults in the Ashanti Region, Ghana.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic has impacted the lives of many including individuals living with chronic illnesses such as Type 2 Diabetes Mellitus (T2DM) in Ghana. This study aimed to explore how people living with T2DM managed their chronic condition during the COVID-19 pandemic.
methodsThis study employed the phenomenological approach where interviews were conducted among 10 participants at the Korle-Bu Teaching Hospital in Ghana. A semi-structured interview guide was used to explore the experiences of participants during the pandemic, focusing on participants' perceptions about COVID-19 and diabetes management, adherence to treatment regimen during the pandemic, experiences of psychological distress, and coping strategies employed. The interviews were transcribed and analysed thematically.
resultsFour themes were identified related to participants' experiences during the COVID-19 pandemic. These were (1) participants' perceptions about COVID-19, (2) changes and challenges with diabetes management, (3) psychosocial impact of COVID-19, and (4) coping with diabetes care during the pandemic. Some participants perceived that having diabetes meant they would automatically get infected with COVID-19. All the participants reported experiencing challenges with their diabetes management during the pandemic though a few of them recorded improvements in diabetes management. Psychosocial effects reported were stigmatisation, fear, worry, and sadness, due to the ban on social gatherings. Notwithstanding these psychosocial challenges, participants indicated that maintaining diabetes care, engaging in recreational activities, support from family, and religious coping, were strategies used to lessen the COVID-19 psychological distress experienced.
conclusionFindings suggest that people with T2DM should be given psychological support and psychoeducation on appropriate coping skills during pandemics and other unexpected occurrences that could affect their diabetes management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.